+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Proton Pump Inhibitors Did Not Increase Risk of Pneumonia in Patients With Chronic Obstructive Pulmonary Disease



Proton Pump Inhibitors Did Not Increase Risk of Pneumonia in Patients With Chronic Obstructive Pulmonary Disease



Journal of Clinical Medicine Research 7(11): 880-883



Chronic obstructive pulmonary disease (COPD) involves the airways and pneumonia is a major cause of mortality. Proton pump inhibitors (PPIs) were found to have a positive association with pneumonia. The aim of this study was to investigate the impact of PPIs on the risk of pneumonia in patients with COPD. This was a nationwide, population-based, case-control study using data from the National Health Insurance Research Database in Taiwan. The enrolled cases were defined as patients with COPD and appearance of pneumonia between 2001 and 2005. The control group was age- and sex-matched 1:2 with the cases without pneumonia. Potential confounders such as coronary artery disease, hypertension, diabetes mellitus, heart failure, chronic kidney disease, and prescriptions of glucocorticoids over 2 weeks, were included in the analysis. Prescriptions for PPIs were identified and entered into the analysis. A total of 10,131 COPD patients, including 3,377 cases with pneumonia and 6,754 without, were identified. There were 213 (5.3%) and 436 (6.5%) cases with concurrent PPIs in the two groups, respectively, and the risk of pneumonia was similar (aOR = 0.96; 95% CI: 0.83 - 1.10). Further subgroup analysis found no differences for younger patients (younger than 70 years old; aOR = 1.04; 95% CI: 0.83 - 1.10), elderly patients (older than 70 years old; aOR = 0.96; 95% CI: 0.81 - 1.15), short-term use of PPIs (less than 30 days; aOR = 1.12; CI: 0.53 - 2.34), medium-term use of PPIs (30 - 90 days; aOR = 0.86; CI: 0.72 - 1.03), or long-term use of PPIs (longer than 90 days; aOR = 0.97; CI: 0.81 - 1.15). PPIs did not contribute to a greater occurrence of pneumonia in COPD patients compared with non-users in this population-based case-control study. Further research is required.

(PDF emailed within 1 workday: $29.90)

Accession: 058654446

Download citation: RISBibTeXText

PMID: 26491501


Related references

Inhaled corticosteroids might not increase the risk of pneumonia in patients with chronic obstructive pulmonary disease in Japan. International Journal of Chronic Obstructive Pulmonary Disease 13: 3503-3509, 2018

Use of inhaled budesonide for 1 year does not increase risk of pneumonia in patients with chronic obstructive pulmonary disease. Evidence-Based Medicine 15(1): 8-9, 2010

Inhaled Corticosteroids Increase the Risk of Pneumonia in Patients With Chronic Obstructive Pulmonary Disease: A Nationwide Cohort Study. Medicine 94(42): E1723, 2016

Proton pump inhibitor usage and the associated risk of pneumonia in patients with chronic kidney disease. Journal of Microbiology, Immunology, and Infection 48(4): 390-396, 2016

Do proton-pump inhibitors increase the risk for nosocomial pneumonia in a medical intensive care unit?. Journal of Critical Care 23(4): 513-518, 2008

Proton pump inhibitors use and risk of chronic kidney disease in diabetic patients. Diabetes Research and Clinical Practice 2018, 2018

Risk of pneumonia with use of inhaled corticosteroids in patients with chronic obstructive pulmonary disease. Indian Journal of Chest Diseases and Allied Sciences 52(4): 195-196, 2011

Patients diagnosed with diabetes are at increased risk for asthma, chronic obstructive pulmonary disease, pulmonary fibrosis, and pneumonia but not lung cancer. Diabetes Care 33(1): 55-60, 2010

Association of Proton Pump Inhibitors Usage with Risk of Pneumonia in Dementia Patients. Journal of the American Geriatrics Society 65(7): 1441-1447, 2017

Risk of pneumonia with inhaled corticosteroids for stable chronic obstructive pulmonary disease patients. Medicina Clinica 137(7): 302-304, 2012

Chronic obstructive pulmonary disease patients have a higher risk of occurrence of pneumonia by air pollution. Science of the Total Environment 677: 524-529, 2019

Risk of small intestinal bacterial overgrowth in patients receiving proton pump inhibitors versus proton pump inhibitors plus prokinetics. Jgh Open 2(2): 47-53, 2018

Risk of community-acquired pneumonia in veteran patients to whom proton pump inhibitors were dispensed. Clinical Infectious Diseases 54(1): 33-42, 2012

Is chronic obstructive pulmonary disease a risk factor for death in patients with community acquired pneumonia?. Infectious Diseases 2019: 1-8, 2019

Association of Increased Risk of Pneumonia and Using Proton Pump Inhibitors in Patients With Type II Diabetes Mellitus. Dose-Response 17(2): 1559325819843383, 2019